Skip to main content

Table 1 Clinical characterization of the patients

From: Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment

Patients

Sex

Age*

Degree of severity*

DID (1: ) - Admission*

Group

Antifungal

Length of treatment (months)**

Length after treatment (months)**

P1

M

60

Moderate

16

NTG

-

-

-

P2

M

53

Severe

128

NTG

-

-

-

P3

M

59

Moderate

32

NTG

-

-

-

P4

F

47

Moderate

64

NTG

-

-

-

P5

M

44

Moderate

64

NTG

-

-

-

P6

M

51

Mild

NR

NTG

-

-

-

P7

M

64

Moderate

32

NTG

-

-

-

P8

M

59

Moderate

32

NTG

-

-

-

P9

M

52

Moderate

8

NTG

-

-

-

P10

M

47

Moderate

32

NTG

-

-

-

P11

M

37

Moderate

4

NTG

-

-

-

P12

M

56

Moderate

16

ACG

CMX

25

28

P13

M

39

Severe

64

ACG

CMX

173

37

P14

M

60

Mild

16

ACG

CMX

97

45

P15

M

56

Moderate

16

ACG

CMX

26

3

P16

M

50

Moderate

512

ACG

CMX

53

62

P17

M

42

Moderate

8

ACG

CMX

28

83

P18

M

42

Moderate

NR

ACG

ITC

31

69

P19

M

39

Moderate

2

ACG

ITC

32

27

P20

M

40

Severe

128

ACG

CMX/ITC

33(CMX)/49(ITC)

89

P21

M

42

Severe

64

ACG

CMX/ITC

6(CMX)/131(ITC)

53

P22

M

51

Severe

128

ACG

CMX/ITC

44(CMX)/12(ITC)

60

P23

M

53

Severe

64

ACG

CMX

84

65

  1. DID = double agar gel immunodiffusion test; NR = non-reagent; NTG = non-treated group; ACG = apparent cure group; CMX = cotrimoxazole; ITC = Itraconazole.
  2. *Homogeneity (NTG x ACG):
  3. Age: NTG =52 (37–64); ACG = 46 (39-60); p =0.18 (Mann–Whitney U test).
  4. Degree of severity: NTG = ACG; p =0.31 (Fisher's exact test).
  5. DID admission: NTG =32 (NR-1:128); ACG =32 (NR-1:512); p =0.66 (Mann-Whitney U test).
  6. **Length of treatment (Mean ± SEM): 68 ± 14; Length after treatment (Mean ± SEM): 52 ± 7.